Thales and Bertin advance CBRN defence with successful PIABC PELICAN trials in biological sampling and identification
Thales and Bertin have achieved a major milestone in the PIABC PELICAN project with successful government-led trials of biological sampling and identification systems.
Conducted by the DGA’s CBRN unit and involving the 2nd Dragoon Regiment and Air and Space Force, the two-week operation tested the integration of key technologies: COLIBRI, BAG, SAULEIL, SPOT, and GENEXPERT.
“These trials validated four years of development and confirmed the system’s operational maturity,” declared project leaders.
The collaboration highlights Thales’s role as a systems architect for both military and civil CBRN solutions. The campaign also served as a platform for defence stakeholders to align on future CBRN innovations and gather field feedback. Backed by the Defence Innovation Agency, the project exemplifies strong public-private cooperation in advancing next-generation protection against chemical and biological threats.
© MIP - Thales
Latest News
- Group
Thales join industry collaboration to shape the future Hybrid Navy
- Europe
Thales in the UK showcases live demonstration of a new remote launcher capability
- Europe
Thales Ready to Deliver Autonomous Capabilities through Project NYX
- Air defence
HYDIS Consortium one step closer to finalising the concept phase
- Europe
Thales in the UK demonstrates drone tracking and interception technology at live demonstration
- Europe
Thales in the UK to integrate Lightweight Multirole Missile for the Spanish Navy
- Drone warfare
At REPMUS26, Thales brings tactical intelligence closer to the field with VORTEX
- Europe
Thales Welcomes New UK Defence Pathways Investment to Support Youth Employment
- Cyber sovereignty
CWIX: an ongoing success story for digital interoperability